QCM
TWST icon

QRG Capital Management’s Twist Bioscience TWST Stock Holding History

QRG Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+2,692
New +$175K ﹤0.01% 1061
2026
Q1 		– Sell
-12,049
Closed -$382K – 1192
2025
Q4 		$382K Buy
12,049
+325
+3% +$10.1K ﹤0.01% 847
2025
Q3 		$330K Sell
11,724
-5,604
-32% -$170K ﹤0.01% 851
2025
Q2 		$637K Sell
17,328
-5,204
-23% -$180K 0.01% 735
2025
Q1 		$885K Sell
22,532
-1,813
-7% -$81.7K 0.01% 614
2024
Q4 		$1.13M Sell
24,345
-3,177
-12% -$144K 0.01% 559
2024
Q3 		$1.24M Sell
27,522
-31,921
-54% -$1.52M 0.01% 537
2024
Q2 		$2.93M Buy
59,443
+4,981
+9% +$203K 0.03% 346
2024
Q1 		$1.87M Sell
54,462
-6,118
-10% -$221K 0.02% 433
2023
Q4 		$2.23M Buy
60,580
+5,142
+9% +$119K 0.03% 379
2023
Q3 		$1.12M Buy
+55,438
New +$1.22M 0.02% 470

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

QRG Capital Management's TWST Position: Q2 2026 in Review

QRG Capital Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,692 shares worth $277K. The stake represents ﹤0.01% of the portfolio and ranks #1061 among its holdings. This is a return to the name: QRG Capital Management previously reported a position in TWST as recently as Q4 2025.

QRG Capital Management first reported a position in TWST in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.93M in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • QRG Capital Management held 2,692 shares of Twist Bioscience worth $277K as of Q2 2026.
  • Twist Bioscience was a new QRG Capital Management position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #1061 holding.
  • QRG Capital Management first reported a position in Twist Bioscience in Q3 2023 and has held it in 11 quarters since.
  • QRG Capital Management's Twist Bioscience position peaked at $2.93M in Q2 2024.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.